In summary, our results provided compelling evidence that BIRC3 knockdown significantly impeded the proliferation and migration of ccRCC cells, suggesting a potential therapeutic strategy for ccRCC treatment. This evidence concerns the gene BIRC3 and nonpapillary renal cell carcinoma.